GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday. Earlier this month, Goldman Sachs … Read more

Novavax to settle Gavi arbitration over canceled Covid shot purchase

Novavax to settle Gavi arbitration over canceled Covid shot purchase

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Thursday said it will settle a bitter arbitration dispute with Gavi, a nongovernmental global vaccine organization, over a … Read more

Moderna (MRNA) earnings Q4 2023

Moderna (MRNA) earnings Q4 2023

Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product.  The results cap a rocky year for the biotech company and other Covid vaccine makers, which all saw revenue plunge … Read more

Alzheimer’s drug Leqembi launch, Apple Vision Pro nausea

Alzheimer’s drug Leqembi launch, Apple Vision Pro nausea

Good afternoon! The launch of the closely watched Alzheimer’s drug Leqembi is off to a slow start. Still, demand for the treatment from Biogen and its Japanese partner Eisai is rising. That’s the update the two drugmakers gave Wall Street during their latest quarterly earnings calls earlier this month. But before we get into the numbers, … Read more

AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez

AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez.  Michael, who is AbbVie’s president and chief operating officer, will become the company’s second-ever CEO … Read more

Elon Musk says Neuralink patient can control a mouse through thinking

Elon Musk says Neuralink patient can control a mouse through thinking

Jonathan Raa | Nurphoto | Getty Images A patient implanted with Neuralink’s brain technology can now control a computer mouse just by thinking, the company’s founder Elon Musk said. “(The) patient seems to have made a full recovery with no ill effects that we are aware of and is able to control the mouse, move … Read more

FTC, HHS examining cause of generic drug shortages

FTC, HHS examining cause of generic drug shortages

A variety of generic pills and capsules.  Nenov | Moment | Getty Images The Federal Trade Commission on Wednesday said it is examining the role that drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs, which account for the majority of Americans’ prescriptions. The move follows an … Read more

Higher medical costs are pinching CVS, UnitedHealth

Higher medical costs are pinching CVS, UnitedHealth

A UnitedHealth Group health insurance card is seen in a wallet, Oct.14, 2019. Lucy Nicholson | Reuters Good afternoon! Health insurers are feeling the squeeze as older patients head to the doctor more than expected. CVS, which owns health insurer Aetna, on Wednesday slashed its full-year profit outlook, citing the potential for higher medical costs to bite … Read more

Medicare drug price negotiations: Judge tosses PhRMA lawsuit

Medicare drug price negotiations: Judge tosses PhRMA lawsuit

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday dismissed a lawsuit brought by a major pharmaceutical industry lobbying group and two other organizations that challenged … Read more

Biogen (BIIB) earnings Q4 2023

Biogen (BIIB) earnings Q4 2023

Biogen on Tuesday reported fourth-quarter revenue and profit that shrank from a year ago, as it recorded charges related to dropping its controversial Alzheimer’s drug Aduhelm and as sales slumped in its multiple sclerosis therapies, the company’s biggest drug category. Biogen booked sales of $2.39 billion for the quarter, down 6% from the same period a … Read more